UAMS startup lands $13.8 million grant for Phase 2 trial to help meth addiction

KATV 7 ABC Little Rock

Nov 1, 2021

UAMS startup InterveXion Thearapeutics, LLC has been awarded a $13. 8 million grant from the National Institutes of Health to fund a three-year Phase 2 clinical trial for a drug to…